{
  "id": "cerebellar-ataxia",
  "title": "Cerebellar ataxia",
  "lang": "en",
  "source_lang": "en",
  "summary": "Cerebellar ataxia is impaired coordination caused by dysfunction of the cerebellum or its connections, arising from diverse acquired and inherited disorders.",
  "category": "health",
  "subcategory": "diseases",
  "type": "concept",
  "aliases": [
    "Cerebellar incoordination",
    "Cerebellar ataxic syndrome"
  ],
  "generated_at": "2026-11-05",
  "model": "pro/gpt-6.1-sol",
  "url": "https://aiwiki.page/en/cerebellar-ataxia/",
  "translations": {
    "zh-Hans": {
      "url": "https://aiwiki.page/zh/cerebellar-ataxia/",
      "json": "https://aiwiki.page/zh/cerebellar-ataxia.json"
    }
  },
  "sections": [
    {
      "heading": "",
      "text": "Cerebellar ataxia is a disturbance of balance, movement coordination, speech, or eye movements caused by dysfunction of the cerebellum and its connections. It is a clinical syndrome rather than a single disease. Affected movements are poorly timed, inaccurately scaled, or irregular despite sufficient strength to perform the intended action. Manifestations range from subtle difficulty walking heel-to-toe to severe instability of the trunk, limbs, and gaze.\n\nThe syndrome can develop abruptly after a stroke, appear during intoxication or an inflammatory illness, recur in discrete episodes, or progress over years because of an inherited or degenerative disorder. Its importance lies partly in this diversity: similar coordination abnormalities may reflect a reversible biochemical disturbance, an acute structural injury, or a chronic disease affecting several parts of the nervous system. Clinical assessment therefore distinguishes the cerebellar syndrome itself from its underlying cause and from sensory or vestibular disorders that also produce imbalance."
    },
    {
      "heading": "Neural organization and mechanisms",
      "text": "The cerebellum lies behind the brainstem and beneath the posterior part of the cerebral hemispheres. Its densely folded cortex receives information about intended movement, actual movement, body position, and balance. These inputs allow ongoing actions to be adjusted and repeated actions to become more accurate. Cerebellar dysfunction generally disrupts coordination rather than abolishing the ability to initiate movement, which helps distinguish it from paralysis.\n\nDifferent cerebellar regions contribute preferentially to different functions. The midline vermis and associated pathways are important for stance, gait, and control of the trunk. Intermediate regions contribute to the adjustment of limb movement, while lateral hemispheric circuits participate in planning and timing skilled actions. The flocculus, nodulus, and related vestibular connections contribute to gaze stability and equilibrium. These divisions are useful clinically, but they are not independent compartments: their connections overlap, and widespread disease commonly produces a mixed syndrome.\n\nThe principal output neurons of the cerebellar cortex are Purkinje cells, which inhibit neurons in the deep cerebellar and vestibular nuclei. Most incoming information reaches the cortex through mossy fibers and granule cells; climbing fibers from the inferior olive provide another powerful input. Cerebellar output returns to motor and nonmotor networks through the thalamus, brainstem, and other structures. Disruption of these circuits can arise from neuronal loss, altered synaptic transmission, damage to connecting fibers, or abnormal electrical activity without immediately visible tissue destruction.\n\nOne influential account of cerebellar function emphasizes prediction. Sensory feedback arrives too late to guide every detail of a rapid movement, so neural circuits estimate the likely consequences of motor commands and compare them with incoming information. Cerebellar injury can impair this prediction and the correction of movement errors. A reaching movement may overshoot its target, require several corrections, or show irregular timing between joints. Cerebellar circuits also contribute to motor adaptation, such as recalibrating reaching movements when visual feedback is experimentally displaced.\n\nThe side and distribution of abnormalities help localize injury. A lesion in one cerebellar hemisphere usually produces limb incoordination on the same side of the body, reflecting the organization of its connections with motor pathways. Midline lesions more often produce prominent truncal or gait instability. However, damage outside the cerebellum—including its brainstem connections or selected pathways in the spinal cord—can interrupt the same functional circuits. Consequently, “cerebellar” describes a physiological pattern and does not always mean that the primary lesion lies within cerebellar tissue."
    },
    {
      "heading": "Clinical manifestations and examination",
      "text": "Gait disturbance is among the most recognizable manifestations. Walking may become broad-based, irregular, and unstable, with variable step length and lateral deviation. Turning and tandem walking, in which one foot is placed directly in front of the other, can expose abnormalities that are less evident during ordinary walking. More severe disease impairs sitting or standing without support. This truncal instability can be particularly prominent when midline cerebellar structures are affected.\n\nLimb testing examines accuracy, rhythm, and the coordination of individual movement components. Dysmetria is an error in movement amplitude, such as overshooting or undershooting a target during finger-to-nose testing. An intention tremor becomes more evident as the hand approaches a target. Rapid alternating movements may become slow, irregular, or poorly sequenced, a finding termed dysdiadochokinesia. Heel-to-shin testing evaluates similar functions in the legs. These abnormalities must be interpreted in relation to strength, joint mobility, vision, and sensation, since impairments in those systems can also degrade performance.\n\nSpeech may be affected by dysarthria, with irregular articulatory breakdown, abnormal stress, variable loudness, and impaired control of rate. The traditional expression “scanning speech” describes separation of speech into unusually distinct syllables, but it does not encompass the full range of cerebellar speech changes. Speech impairment is not equivalent to aphasia: language formulation and comprehension may remain intact even when articulation is severely disrupted. Swallowing impairment can occur, especially in advanced or multisystem disorders, although its mechanism may extend beyond cerebellar dysfunction.\n\nEye movements provide additional localization clues. Nystagmus is a rhythmic oscillation of the eyes; gaze-evoked and downbeat forms are particularly relevant to cerebellar assessment. Smooth pursuit may be replaced by a series of corrective saccades, while voluntary saccades may overshoot or undershoot their targets. Impaired suppression of the vestibulo-ocular reflex can also occur. Oscillopsia—the perception that the visual environment is moving—may result from unstable gaze, but some examination abnormalities produce little subjective visual disturbance.\n\nCerebellar disease can also affect cognition and behavior. The cerebellar cognitive affective syndrome, described by Jeremy Schmahmann and Janet Sherman in 1998, includes difficulties with executive function, visuospatial processing, language regulation, and emotional modulation. It is associated particularly with posterior cerebellar and vermal involvement. These features vary substantially and are not inevitable in a person with motor ataxia. Clinical interpretation also accounts for extracerebellar disease, medications, sleep disturbance, and mood, each of which can influence cognitive performance."
    },
    {
      "heading": "Acquired causes and patterns of onset",
      "text": "The time course is a major organizing feature of acquired cerebellar ataxia. Symptoms developing within minutes or hours can result from ischemic stroke, hemorrhage, intoxication, or an acute metabolic disturbance. Cerebellar infarction may produce severe gait instability, vertigo, vomiting, and eye-movement abnormalities, sometimes without obvious limb weakness. Swelling in the confined posterior cranial fossa can compress the brainstem or obstruct cerebrospinal fluid circulation. Thus, the seriousness of an acute cerebellar lesion is not determined solely by the degree of limb incoordination.\n\nDrugs and toxic exposures are important causes of acute or subacute dysfunction. Alcohol intoxication commonly disrupts gait and coordination; prolonged heavy exposure can also produce structural cerebellar injury, often with prominent involvement of the anterior superior vermis. Phenytoin, lithium, sedative drugs, and some antineoplastic agents can produce cerebellar abnormalities under particular exposure conditions. Toxicity may reflect excessive concentrations, altered elimination, drug interactions, or individual susceptibility. These mechanisms differ from the progressive neuronal dysfunction of inherited ataxias, even when the examination looks similar.\n\nNutritional and metabolic causes include thiamine deficiency and vitamin E deficiency. Thiamine deficiency can produce Wernicke encephalopathy, in which ataxia may accompany altered mental status and ocular motor abnormalities; the complete classic triad is not always present. Vitamin E deficiency can cause a combination of cerebellar dysfunction and peripheral sensory impairment. Vitamin B12 deficiency more often causes sensory ataxia through damage to proprioceptive pathways, illustrating why nutritional causes cannot be classified from gait appearance alone. Endocrine and systemic metabolic disturbances may also contribute to impaired coordination.\n\nInflammatory and infectious conditions produce several distinct patterns. Multiple sclerosis can interrupt cerebellar pathways through demyelination. Acute postinfectious cerebellar ataxia occurs particularly in children, often after a viral illness; direct infectious cerebellitis is a related but distinct process that may involve more substantial inflammation and swelling. Immune-mediated cerebellar syndromes include some disorders associated with glutamic acid decarboxylase antibodies, gluten-related disease, and systemic autoimmune disease. The significance of an antibody depends on its specificity, concentration, testing method, and the accompanying clinical findings.\n\nParaneoplastic cerebellar degeneration is an immune-mediated complication of cancer and may precede recognition of the tumor. Certain antibodies, including anti-Yo and anti-DNER antibodies, are associated with characteristic cancer contexts, although neither an antibody result nor a cancer history alone establishes the diagnosis. Structural causes include posterior fossa tumors, trauma, and disorders affecting cerebrospinal fluid flow. Slowly progressive acquired or sporadic ataxia can also occur in the cerebellar form of multiple system atrophy, where autonomic failure and other neurological signs help distinguish it from a predominantly cerebellar disorder."
    },
    {
      "heading": "Inherited and episodic disorders",
      "text": "Inherited ataxias encompass many diseases rather than a single genetic category. They may follow autosomal dominant, autosomal recessive, X-linked, or mitochondrial inheritance. Some remain largely cerebellar for many years, whereas others involve peripheral nerves, vision, hearing, cognition, the heart, or endocrine organs. Age at onset ranges from infancy to late adulthood. A negative family history does not exclude an inherited cause: recessive inheritance, small families, reduced penetrance, new variants, and late onset can all obscure familial patterns.\n\nThe dominant spinocerebellar ataxias are conventionally numbered as distinct genetic entities. Several common forms, including SCA1, SCA2, SCA3, SCA6, and SCA7, result from expanded CAG repeats that encode abnormally long polyglutamine tracts in particular proteins. Their manifestations differ: retinal degeneration is characteristic of SCA7, while SCA6 often has a relatively restricted cerebellar phenotype. Repeat size can influence age at onset and severity, but it does not predict an individual course precisely. Some repeat disorders show anticipation, in which disease appears earlier in successive generations because the repeat expands during transmission.\n\nFriedreich ataxia is usually caused by expanded GAA repeats in both copies of the FXN gene, leading to reduced frataxin expression and impaired mitochondrial function. Despite its name, its neurological basis includes marked involvement of sensory pathways and the spinal cord as well as cerebellar-related systems. Loss of tendon reflexes, impaired position sense, and extensor plantar responses may coexist. Cardiomyopathy, skeletal deformity, and diabetes mellitus are important extracerebral manifestations. Ataxia-telangiectasia, caused by pathogenic variants in ATM, instead combines progressive neurological dysfunction with abnormalities of DNA damage responses, variable immunodeficiency, and increased cancer susceptibility.\n\nRepeat expansions have also clarified previously unexplained adult-onset disease. Biallelic pathogenic expansions in RFC1, identified in 2019, account for many cases of cerebellar ataxia, neuropathy, and vestibular areflexia syndrome, usually abbreviated CANVAS. Sensory neuronopathy, bilateral vestibular impairment, and sometimes a longstanding cough accompany or precede cerebellar signs. A GAA expansion in FGF14, reported in 2023 and designated SCA27B, is another important cause of late-onset ataxia. Episodic symptoms and downbeat nystagmus can be prominent. These discoveries demonstrate why standard sequencing alone does not detect every relevant genetic abnormality.\n\nEpisodic ataxias produce recurrent attacks rather than exclusively continuous impairment, although persistent abnormalities can develop. Episodic ataxia type 1 is associated with KCNA1 and often includes myokymia; type 2 is associated with CACNA1A and commonly produces longer attacks with interictal nystagmus. These genes encode ion-channel components, making the disorders examples of channelopathies. Exercise, physiological stress, or other triggers can influence attack occurrence. The same gene may produce different neurological phenotypes, so the relationship between a molecular finding and a clinical syndrome requires careful interpretation."
    },
    {
      "heading": "Diagnostic reasoning and investigations",
      "text": "The diagnostic process begins by establishing whether impaired coordination is predominantly cerebellar. In sensory ataxia, loss of proprioceptive input interferes with knowledge of limb position; imbalance often becomes substantially worse when visual compensation is removed. Vestibular disorders impair balance through disturbed motion and orientation signals and may produce vertigo, nystagmus, and instability. Cerebellar, sensory, and vestibular deficits can coexist, especially in disorders such as RFC1-related disease. Musculoskeletal limitations, weakness, medication effects, and functional neurological symptoms also enter the differential diagnosis.\n\nA detailed medical history establishes onset, progression, fluctuation, exposures, and accompanying symptoms. Abrupt, stepwise, steadily progressive, and episodic courses suggest different causal categories. Relevant associated features include sensory loss, autonomic dysfunction, seizures, cognitive change, visual impairment, and systemic illness. A family history extends beyond relatives explicitly labeled as having ataxia, because unexplained gait impairment or a different neurological diagnosis may represent the same inherited disorder. The physical examination evaluates eye movements, speech, stance, gait, limb coordination, reflexes, sensation, strength, and signs outside the cerebellar system.\n\nMagnetic resonance imaging is central to evaluating structural disease and patterns of degeneration. It can identify infarction, tumors, demyelinating lesions, malformations, and cerebellar or brainstem atrophy. Diffusion-weighted imaging is particularly useful for acute ischemia, although early posterior circulation lesions can occasionally be missed. Atrophy is a descriptive finding, not a complete diagnosis: it may occur in numerous inherited, toxic, immune-mediated, and degenerative conditions. Conversely, substantial physiological dysfunction can occur before clear atrophy develops. Computed tomography has particular value in some acute settings, including the detection of hemorrhage, but provides less detailed assessment of many posterior fossa abnormalities.\n\nLaboratory testing is selected according to the clinical pattern rather than applied as an undifferentiated panel. Investigations may assess nutritional status, thyroid function, metabolic disturbances, infection, and immune-mediated disease. Cerebrospinal fluid examination can provide evidence of inflammation, infection, or selected malignancies when those possibilities are clinically relevant. Nerve conduction studies help identify accompanying peripheral neuropathy or sensory neuronopathy, while vestibular testing characterizes impaired vestibulo-ocular responses. None of these tests substitutes for interpretation of the overall syndrome.\n\nGenetic evaluation increasingly includes both sequencing and dedicated repeat-expansion assays. Conventional exome sequencing may fail to detect important expansions, including those responsible for several common adult-onset ataxias. Results can also reveal variants of uncertain significance that do not establish causation. Genetic counseling addresses inheritance, the limits of testing, implications for relatives, and the distinction between diagnostic and predictive testing. Even after extensive investigation, some progressive ataxias remain unexplained; a descriptive diagnosis records the phenotype without implying that all possible causes have been excluded permanently."
    },
    {
      "heading": "Cause-directed and symptomatic treatment",
      "text": "Treatment depends on the underlying disorder, because cerebellar ataxia is not a single therapeutic target. Management of an infarct, an intoxication, an immune-mediated syndrome, and an inherited degeneration involves different mechanisms and evidence. Some causes are substantially reversible, especially when dysfunction reflects a biochemical disturbance rather than extensive neuronal loss. In other conditions, treatment primarily seeks to slow progression, reduce particular symptoms, prevent complications, or preserve participation in everyday activities.\n\nFor acquired disease, established approaches include correction of documented nutritional deficiencies, treatment of the responsible infection where applicable, and management of a causative toxic exposure. Thiamine replacement addresses the biochemical defect in thiamine-deficiency syndromes, while vitamin E replacement is relevant to specific deficiency states. Structural lesions may require neurosurgical or oncological treatment according to their nature. Acute vascular disease is managed within stroke care pathways, including assessment for reperfusion treatment or management of hemorrhage and posterior fossa swelling when relevant.\n\nImmune-mediated ataxias require a different framework. Depending on the defined disorder, treatment may involve corticosteroids, intravenous immunoglobulin, or other immunotherapies. Evidence strength varies considerably across subtypes, and apparent immune markers do not necessarily demonstrate that immune treatment will be effective. In paraneoplastic syndromes, treatment of the associated tumor is a major component of care, but neurological recovery can be limited when Purkinje cells have already been lost. This distinction between suppressing an active cause and reversing established injury is important when interpreting outcomes.\n\nDrug treatment is more specific for certain inherited syndromes. Acetazolamide reduces attacks in some people with episodic ataxia, particularly type 2; aminopyridines also have evidence in selected episodic and ocular motor disorders. These effects do not establish efficacy across all progressive cerebellar diseases. In 2023, the United States approved omaveloxolone for Friedreich ataxia in adults and adolescents aged 16 years and older. Its approval concerned a defined molecular disease and was based on disease-specific clinical evidence; it is not a general treatment for cerebellar ataxia and does not reverse all manifestations of Friedreich ataxia.\n\nSymptomatic treatment may address nystagmus, painful muscle overactivity, sleep disturbance, or other associated problems, with choices depending on the particular diagnosis and functional impact. Some drugs that help one symptom can worsen alertness or balance, complicating the assessment of benefit. Advanced multisystem disease may also require management of swallowing impairment, autonomic failure, cardiomyopathy, or respiratory complications. These interventions target associated pathology rather than coordination alone, and their importance can exceed that of a modest change in an ataxia rating score."
    },
    {
      "heading": "Rehabilitation, communication, and daily function",
      "text": "Rehabilitation addresses the consequences of impaired coordination even when its cause cannot be eliminated. The underlying rationale combines practice-dependent learning, use of preserved neural systems, compensatory strategies, and adaptation of the physical environment. Cerebellar injury can impair certain forms of motor adaptation, but this does not mean that all learning is absent. Repetition, explicit strategies, task-specific practice, and external feedback can support performance through partially preserved cerebellar circuits and other brain networks.\n\nPhysical therapy commonly focuses on balance, gait, transfers, trunk control, strength, and endurance. Studies of intensive coordination and balance programs have reported improvements in selected people with degenerative cerebellar disorders. Interpretation is limited by small samples, diverse diagnoses, differing intervention intensity, and variable follow-up. Gains in a practiced task do not necessarily indicate that the underlying degeneration has slowed, and benefits measured immediately after training may differ from those maintained months later. Research therefore distinguishes improvement in performance from modification of disease biology.\n\nOccupational therapy examines how ataxia affects dressing, eating, writing, household activities, education, and employment. Performance depends on more than limb accuracy: fatigue, posture, vision, cognitive demands, and the arrangement of objects can change the difficulty of a task. Adaptations may include altered work surfaces, supported positioning, modified utensils, computer access methods, and changes to task sequence. Assistive technology ranges from simple mobility devices to powered wheelchairs and electronic communication systems. Its role is to improve access and independence, not to define a person’s neurological prognosis.\n\nSpeech-language therapy addresses intelligibility, communication efficiency, and swallowing. Speech interventions may work on pacing, articulation, breath support, or strategies that reduce communication breakdown. Augmentative and alternative communication can supplement speech when verbal output becomes difficult to understand. Swallowing assessment evaluates the specific physiological problem rather than assuming that all people with ataxia share the same risk. Aspiration, inadequate intake, and prolonged mealtimes can become important in some advanced disorders, especially when brainstem or peripheral neuromuscular involvement accompanies cerebellar signs.\n\nRehabilitation outcomes extend beyond examination findings. A person may retain the same degree of dysmetria while becoming more independent through equipment, environmental changes, or improved task organization. Conversely, a small improvement on a coordination test may have little effect on employment or social participation. Health-related quality of life, falls, fatigue, communication, and caregiver workload therefore provide complementary information. Accessibility, transportation, workplace flexibility, and continuity of services influence disability alongside biological disease severity. These contextual factors are especially important in slowly progressive conditions, where support requirements change over many years."
    },
    {
      "heading": "Epidemiology, natural history, and prognosis",
      "text": "There is no single meaningful prevalence estimate for cerebellar ataxia as a whole. The term combines transient toxic syndromes, acute injuries, rare inherited diseases, and sporadic degenerative disorders. Studies may count only genetically confirmed cases, include undiagnosed progressive ataxia, or incorporate mixed sensory-cerebellar syndromes. Population age, referral patterns, access to genetic testing, and the definition of a case all influence the result. Estimates for an individual inherited subtype therefore cannot be generalized to every person with cerebellar signs.\n\nThe geographical distribution of inherited disorders is uneven. Founder effects can make a rare pathogenic variant relatively frequent in a particular population, while migration changes its distribution over time. Friedreich ataxia is more common in populations of European ancestry than in many other ancestry groups, and the relative frequencies of dominant spinocerebellar ataxias vary widely between regions. Recognition of RFC1- and FGF14-related disorders has also changed the composition of adult-onset ataxia cohorts by assigning molecular diagnoses to cases formerly classified as unexplained.\n\nNatural history is determined more by cause than by the initial severity of incoordination. A toxic or metabolic syndrome may improve substantially after the disturbance resolves. A single vascular injury may leave a stable deficit followed by partial functional recovery. Episodic disorders can produce repeated attacks with relatively preserved function between them, although persistent impairment sometimes develops. In degenerative disorders, progression may be gradual, but the pace differs between diseases and between individuals with the same molecular diagnosis. Plateaus and fluctuations can complicate short-term interpretation.\n\nAssociated pathology often determines survival and major complications. Cardiomyopathy is important in Friedreich ataxia; autonomic and respiratory complications are important in multiple system atrophy; cancer and infection susceptibility influence outcomes in ataxia-telangiectasia. Advanced neurological disease may involve aspiration, reduced mobility, falls, or injuries. It is therefore inaccurate to infer life expectancy from the label “cerebellar ataxia” alone. Pure or predominantly cerebellar disorders can have a very different course from diseases that involve vital autonomic, cardiac, or immune functions.\n\nThe burden of disease includes uncertainty as well as motor disability. A prolonged diagnostic process can affect educational, occupational, and family planning decisions, while variable expressivity limits precise forecasts even after a genetic diagnosis. Patient-reported outcomes capture problems that may be underestimated during a brief examination, including fluctuating function, fatigue, fear of falling, and communication difficulty. Longitudinal care and research consequently evaluate both neurological impairment and its effects on daily life, rather than treating walking ability as the sole indicator of disease severity."
    },
    {
      "heading": "Historical development, measurement, and research",
      "text": "Experimental and clinical work gradually separated cerebellar incoordination from weakness and sensory loss. In the nineteenth century, Marie Jean Pierre Flourens used animal lesion experiments to associate the cerebellum with coordinated movement. Later work by Luigi Luciani emphasized disturbances of strength regulation, tone, and steadiness after cerebellar injury. Joseph Babinski described clinical signs including asynergia and dysdiadochokinesia, while Gordon Holmes developed detailed accounts of human cerebellar syndromes from focal injuries, including wartime cases. These observations established much of the vocabulary still used in neurological examination.\n\nThe hereditary ataxias were initially classified chiefly by clinical appearance, inheritance pattern, and pathological findings. Nikolaus Friedreich described the disorder now bearing his name in a series of publications beginning in 1863. Pierre Marie’s late nineteenth-century descriptions helped distinguish other familial ataxic presentations, although historical categories did not correspond neatly to modern molecular diagnoses. Identification of causal genes and repeat expansions from the 1990s onward reorganized classification. Disorders once grouped together were separated, while apparently different syndromes were sometimes shown to share a genetic basis.\n\nStandardized scales make change more reproducible than an unstructured description. The Scale for the Assessment and Rating of Ataxia, introduced in 2006, scores eight items covering gait, stance, sitting, speech, and limb coordination. Its total ranges from 0 to 40, with higher values indicating greater impairment. The earlier International Cooperative Ataxia Rating Scale has a broader 100-point structure. Disease-specific instruments, including modified Friedreich ataxia scales, incorporate features relevant to particular conditions. These measures are useful but remain influenced by examiner judgment and by impairments outside the cerebellum.\n\nResearch increasingly combines clinical scales with quantitative movement analysis, eye tracking, wearable sensors, imaging, and fluid biomarkers. Digital measures can sample walking or upper-limb function repeatedly, potentially capturing fluctuations missed during clinic visits. Imaging can quantify regional tissue loss or altered connectivity, while markers such as neurofilament light may reflect neural injury in some diseases. A marker associated with severity is not automatically a validated surrogate endpoint: demonstrating that it reliably predicts meaningful treatment benefit requires additional evidence.\n\nTherapeutic development includes approaches aimed at toxic repeat-containing RNA, abnormal proteins, mitochondrial dysfunction, and altered neuronal excitability. Antisense strategies, gene-silencing methods, and gene therapy are under investigation for selected molecular disorders, rather than for ataxia as one undifferentiated syndrome. Designing a clinical trial is difficult when populations are small, progression is slow, and outcome measures vary with disease stage. Genetically characterized cohorts, natural-history studies, and blinded randomized comparisons help distinguish treatment effects from ordinary fluctuation, practice effects, and differences in the expected course of disease."
    }
  ],
  "links": [
    "cerebellum",
    "stroke",
    "nervous-system",
    "brainstem",
    "spinal-cord",
    "dysarthria",
    "aphasia",
    "intracerebral-hemorrhage",
    "vitamin-b12",
    "multiple-sclerosis",
    "demyelination",
    "autoimmune-disease",
    "cancer",
    "diabetes-mellitus",
    "channelopathy",
    "differential-diagnosis",
    "medical-history",
    "physical-examination",
    "magnetic-resonance-imaging",
    "cerebrospinal-fluid",
    "neurosurgery",
    "corticosteroid",
    "rehabilitation",
    "physical-therapy",
    "occupational-therapy",
    "assistive-technology",
    "speech-language-therapy",
    "health-related-quality-of-life",
    "life-expectancy",
    "patient-reported-outcome",
    "biomarker",
    "surrogate-endpoint",
    "gene-therapy",
    "clinical-trial"
  ],
  "sources": [],
  "license": "https://creativecommons.org/licenses/by/4.0/"
}